{'fraction_non_alphanumeric': 0.033707865168539325, 'fraction_numerical': 0.010214504596527068, 'mean_word_length': 5.163522012578617, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Quantitation of serum gentamicin concentration by a solid-phase immunofluorescence method.

We describe the use of a solid-phase immunofluorescence method (FIAX system) for measuring drug concentrations, specifically gentamicin, in serum or plasma. Antibody to gentamicin is immobilized on a polymeric surface. This Sampler is immersed in a mixture of serum standard or unknown and a buffered solution of fluorescent-labeled gentamicin. After 30 min, the fluorescence of the specifically bound labeled gentamicin is measured with a fluorometer. The assay detects gentamicin in concentrations as low as 50 mug/L. It is specific for gentamicin, cross reactivity to some other therapeutic drugs, except netilmicin and sisomicin, being low. Results by this assay compare well with those by a radioimmunoassay (r = 0.94) and a radioenzymic assay (r = 0.95). The assay is specific, economical, simply performed, requires little pipetting, and does not involve the use of radioisotopes.